X. Yan

Knockdown of KRT17 decreases osteosarcoma cell proliferation and the Warburg effect via the AKT/mTOR/HIF1α pathway

B. Qiu, X. Yan, Chao-wen Yang, 2020, Oncology reports.

TXNDC5 contributes to rheumatoid arthritis by down‐regulating IGFBP1 expression

L. Zhang, X. Chang, X. Yan, 2018, Clinical and experimental immunology.

MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7.

H. Dong, X. Yan, L-J Wang, 2021, European review for medical and pharmacological sciences.

Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma cell.

X. Yan, H-B Sun, H-Y Zheng, 2014, European review for medical and pharmacological sciences.

CD38 and E2F transcription factor 2 have uniquely increased expression in rheumatoid arthritis synovial tissues

L. Yue, X. Yan, X. Chang, 2014, Clinical and experimental immunology.

The effect of knocking-down nucleostemin gene expression on the in vitro proliferation and in vivo tumorigenesis of HeLa cells.

L. Yajun, L. Weide, L. Xiaolei, 2004, Journal of experimental & clinical cancer research : CR.

Relationship between CD44v6 expression and metastatic potential and prognosis in gastric carcinoma.

W. Yanping, X. Yan, Z. Yinchang, 2000, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.

Lower miR-630 expression predicts poor prognosis of osteosarcoma and promotes cell proliferation , migration and invasion by targeting PSMC 2

X. Yan, L. G.W., 2019 .